DG

Dhanashri Ghanshyamji Totla

Active Director Director DIN 08187178
DIN 08187178 First appointment Jul 2018 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Dhanashri Ghanshyamji Totla

Data last updated:

Dhanashri Ghanshyamji Totla is a Director at Facere Pharma Private Limited (since 2018). The company operates in Business Services.

DIN 08187178
Primary Designation Director
Industry Business Services
First Appointment 26 Jul 2018
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Facere Pharma Private Limited U74999MH2018PTC312240
Director26 Jul 20182018Active

Board colleagues of Dhanashri Ghanshyamji Totla

NameDINCompanyDesignation
Anand Kacharulal Sabu08187179Facere Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Facere Pharma Private Limited
Premium access

Shareholding and investment profile for Dhanashri Ghanshyamji Totla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dhanashri Ghanshyamji Totla

Dhanashri Ghanshyamji Totla currently holds 1 directorship: Facere Pharma Private Limited (Director, since 26 Jul 2018).

Dhanashri Ghanshyamji Totla was first appointed on 26 Jul 2018 as Director at Facere Pharma Private Limited.

The current boards of Dhanashri Ghanshyamji Totla's companies include Anand Kacharulal Sabu (Facere Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available